The MarketWatch News Department was not involved in the creation of this content.-- Cebranopadol is an investigational first-of-its kind dual NOP/MOP receptor (NMR) agonist which ...
Physical therapy (PT) is used in the management of many medical conditions. But variation in rates paid by commercial insurers can contribute to high out-of-pocket costs, leading some patients to ...
CD25 rewires oncogene signaling in AML and ALL, revealing druggable complexes and a bold strategy: push pathways into toxic ...
When we are ill, we need expertise more than ever, yet our agency feels fragile. The best clinicians recognize this, a ...
Acute myeloid leukemia (AML) is a particularly aggressive form of blood cancer that usually progresses rapidly if swift and intensive treatment is not applied. Although the disease can often be ...
The annual meeting of the Post-Acute Long-Term Care Medical Association (PALTmed) will run March 26-28 in Anaheim.
Lawmakers approved $16.7 million to seed new residency programs at St. Joseph’s/Candler to train and retain doctors for ...
In this installment in our series about diseases preventable by vaccination, we examine hepatitis A and why protection from ...
SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today that it has completed the required enrollment in the ...
Acute myeloid leukemia (AML) is a particularly aggressive form of blood cancer that usually progresses rapidly if swift and intensive treatment is not applied. Although the disease can often be ...
The move is a big winner for patients and doctors that the AMA fought for to help boost care, cut postdischarge costs and ...
During the COVID-19 pandemic, there were global concerns that children with cancer might experience delayed diagnoses and disruptions to treatment, which in turn could worsen prognosis. However, a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results